InsidersTradesSigma
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
9
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Angotti Vincent J., Chairman & CEO. Director active across 2 companies, notably Acelrx Pharmaceuticals INC. Cumulatively, 25 reports have been recorded. Split: 9 buys · 0 sell. Total volume traded: €264k. Activity tracked since 6 February 2022. The latest transaction was filed on 2 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Angotti Vincent J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
9,938 shares@ US$0.72234.0% of flowCommon StockSEC:0001700225-26-000004:0
213,310 shares@ US$0.58640.9% of flowCommon StockSEC:0001700225-26-000003:0
Canonical exit: 11 Jun 2026 (T+90)
3,179 shares@ US$0.83610.8% of flowCommon StockSEC:0001700225-26-000002:0
213,310 shares@ US$0.58676.0% of flowCommon StockSEC:0001415889-25-009947:0
Canonical exit: 1 Jul 2025 (T+90)
10,575 shares@ US$0.674.5% of flowCommon StockSEC:0001415889-25-004440:0
3,515 shares@ US$0.62991.4% of flowCommon StockSEC:0001415889-25-003721:0
5,000 shares@ US$0.63992.0% of flowCommon StockSEC:0001415889-24-028440:0
Canonical exit: 5 Mar 2025 (T+90)
5,000 shares@ US$0.72992.3% of flowCommon StockSEC:0001415889-24-027989:0
Canonical exit: 25 Feb 2025 (T+90)
7,260 shares@ US$1.04664.5% of flowCommon StockSEC:0001415889-24-022690:0
Canonical exit: 28 Nov 2024 (T+90)
4,126 shares@ US$0.97272.5% of flowCommon StockSEC:0001415889-24-016974:0
Canonical exit: 10 Sept 2024 (T+90)
1,000 shares@ US$1.1150.7% of flowCommon StockSEC:0001415889-24-007710:0
1,623 shares@ US$1.301.3% of flowCommon StockSEC:0001209191-24-004243:0
58,667 shares0Common StockSEC:0001209191-24-004042:0
3,320 shares@ US$1.102.2% of flowCommon StockSEC:0001209191-24-003304:0
3,723 shares@ US$1.102.5% of flowCommon StockSEC:0001209191-24-003304:1
10,000 shares@ US$0.726810.5% of flowCommon StockSEC:0001209191-23-058578:0
Canonical exit: 12 Mar 2024 (T+90)
10,000 shares@ US$0.79511.6% of flowCommon StockSEC:0001209191-23-049016:0
Canonical exit: 10 Dec 2023 (T+90)
1,703 shares@ US$1.313.3% of flowCommon StockSEC:0001209191-23-016311:0
3,321 shares@ US$1.688.1% of flowCommon StockSEC:0001209191-23-009115:1
19,500 shares0Common StockSEC:0001209191-23-009115:0
1,982 shares@ US$2.025.8% of flowCommon StockSEC:0001209191-23-007814:0
46,400 shares@ US$0.222725.0% of flowCommon StockSEC:0001209191-22-035010:0
Canonical exit: 5 Sept 2022 (T+90)
23,051 shares@ US$0.406821.8% of flowCommon StockSEC:0001209191-22-016238:0
390,000 shares0Common StockSEC:0001209191-22-009343:0
27,318 shares@ US$0.431226.6% of flowCommon StockSEC:0001209191-22-007622:0
25 of 25 declarations
About Angotti Vincent J.
Vincent J. Angotti is the Chief Executive Officer of AcelRx Pharmaceuticals Inc. He is responsible for the strategic direction of the company and the management of its operations. With experience in the pharmaceutical sector, he is committed to promoting innovation and enhancing the therapeutic solutions offered by the company.
